HALLETT DAVID (Chief Scientific Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/19/2026ACC: 0002006495-26-000010
Officer· Chief Scientific Officer
Since Feb 2026
-26.66K
Net shares
Net seller
$81.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
26.66K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−26.66K
Price / share
$3.04
Trade value
$81.04K
% of position
2.4%
5/15/2026
1.10M→1.07M
Total
Net shares
−26.66K
Net value
-$81.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/15/2026 | F · Tax Withholding | −26.66K | $3.04 | $81.04K | 2.4% | 1.10M | 1.07M |
| Total | −26.66K | -$81.04K | ||||||
Derivative Transactions0
No derivative transactions reported